SACITUZUMAB TIRUMOTECAN
UNII 3DV5TD1VL3

Substance Identification & Data

This profile provides standardized clinical and technical data for Sacituzumab Tirumotecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3DV5TD1VL3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2768350-77-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3DV5TD1VL3

CAS Registry Number

2768350-77-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SACITUZUMAB TIRUMOTECAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166409

National Cancer Institute reference terminology for clinical and research data.

INN ID

12801

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-68

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sacituzumab Tirumotecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SACITUZUMAB TIRUMOTECAN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2) (HUMAN-MUS MUSCULUS MONOCLONAL HRS7 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HRS7 .KAPPA.-CHAIN, DIMER, REDUCED, S-(5-(6-(((1-((34S)-38-AMINO-34-(((4-((((((4S)-4-ETHYL-3,4,12,14-TETRAHYDRO-11-(2-((1-METHYLETHYL)(METHYLSULFONYL)AMINO)ETHYL)-3,14-DIOXO-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-4-YL)OXY)CARBONYL)OXY)METHYL)PHENYL)AMINO)CARBONYL)-28,32-DIOXO-3,6,9,12,15,18,21,24,30-NONAOXA-27,33-DIAZAOCTATRIACONT-1-YL)-1H-1,2,3-TRIAZOL-4-YL)METHYL)AMINO)-6-OXO-1-HEXYN-1-YL)-2-PYRIMIDINYL)-L-CYSTEINE

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TACSTD2 (TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2, MEMBRANE COMPONENT CHROMOSOME 1 SURFACE MARKER 1, M1S1, GASTROINTESTINAL TUMOR-ASSOCIATED ANTIGEN GA7331, PANCREATIC CARCINOMA MARKER PROTEIN GA733-1, EPITHELIAL GLYCOPROTEIN-1, EGP-1, TROPHOBLAST ANTIGEN-2, CELL SURFACE GLYCOPROTEIN TROP-2, TROP2)), HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED TO THE TOPOISOMERASE I INHIBITOR TIRUMOTECAN

SACITUZUMAB TIRUMOTECAN [INN]

SACITUZUMAB TIRUMOTECAN [USAN]

SACITUZUMAB TIRUMOTECAN [WHO-DD]